Co-Diagnostics
CODX
86 hedge funds and large institutions have $129M invested in Co-Diagnostics in 2020 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 9 closing their positions.
693% more capital invested
Capital invested by funds: $16.3M → $129M (+$113M)
456% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 9
91% more funds holding
Funds holding: 45 → 86 (+41)
81% more call options, than puts
Call options by funds: $32.4M | Put options by funds: $17.8M
64% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 11
0.53% more ownership
Funds ownership: 0.28% → 0.81% (+0.53%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$27.4M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.99M |
| 3 |
State Street
Boston,
Massachusetts
|
+$7.24M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$4.37M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$3.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$3.07M |
| 2 |
Millennium Management
New York
|
-$1.1M |
| 3 |
Jane Street
New York
|
-$1.03M |
| 4 |
WA
Wealth Architects
Mountain View,
California
|
-$305K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$301K |
CODX Hedge Fund Activity: Q2 2020 in Review
86 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q2 2020, worth a combined $129M — up 693% from $16.3M a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new CODX positions and 9 closed out — a net gain of 41 holders — while 18 added to existing stakes and 11 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $27.4M. The largest seller was Morgan Stanley, cutting an estimated $3.07M.
- 86 institutional investors held Co-Diagnostics (CODX) as of Q2 2020, up from 45 in Q1 2020.
- Funds reported $129M of Co-Diagnostics stock for Q2 2020, up 693% quarter-over-quarter.
- 50 funds opened new Co-Diagnostics positions in Q2 2020 and 9 closed out, a net change of +41 holders.
- The largest Co-Diagnostics buyer in Q2 2020 was BlackRock, an estimated $27.4M added.
- The largest Co-Diagnostics seller in Q2 2020 was Morgan Stanley, an estimated $3.07M sold.
Based on aggregated 13F filings for Q2 2020.